Reply to "MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing
Carolin Lackner1, Annette S H Gouw2, Dina G Tiniakos3
1ZLP - Zentrum für Leber- & Pankreaspathologie, ADK Diagnostics, Vienna, Austria; Institute of Pathology, Medical University of Graz, Austria.
Journal of Hepatology
|January 11, 2026
Abstract
No abstract available in PubMed .


